Literature DB >> 20550764

Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia.

K Shanaube1, P De Haas, A Schaap, M Moyo, B Kosloff, A Devendra, E Raby, P Godfrey-Faussett, H Ayles.   

Abstract

BACKGROUND: Interferon-gamma (IFN-gamma) release assays (IGRAs), such as the QuantiFERON-TB Gold In-Tube test (QFT-GIT), are becoming a preferred method for diagnosis of tuberculosis (TB) infection in many industrialised countries. However, data on the effectiveness of IGRAs in high TB-HIV (human immunodeficiency virus) endemic and resource-limited settings, such as Zambia, are limited.
OBJECTIVE: To determine the intra-assay reliability and robustness of QFT-GIT in a field setting in Zambia.
DESIGN: During July-October 2007, 109 adult smear-positive TB patients were recruited to determine QFT-GIT reliability and the effect of a 24-h delay in incubation. Two simulated laboratory experiments were also performed using 9-14 volunteers, to explore the effect of power outages during incubation and storage temperature of collection tubes on IFN-gamma responses.
RESULTS: QFT-GIT intra-assay concordance was 91.7% (kappa = 0.8). Discordance was observed for nine patients, of whom six were HIV-positive. There was evidence of an association between HIV status and discordant results (OR 1.98, 95%CI 1.06-3.67, P = 0.03). A 24-h delay in incubation changed results for 25 of the 109 (22.9%) patients. Power outages that altered incubation time reduced IFN-gamma responses.
CONCLUSION: Although QFT-GIT seems reliable in this setting, we have identified operational factors that affect its robustness. These factors may influence the effectiveness of this test in similar resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550764

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  12 in total

1.  Validation of increased blood storage times with the T-SPOT.TB assay with T-Cell Xtend reagent in individuals with different tuberculosis risk factors.

Authors:  Shu-Hua Wang; Samuel S Stew; Joshua Cyktor; Bridget Carruthers; Joanne Turner; Blanca I Restrepo
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

2.  Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection.

Authors:  David Doberne; Rajiv L Gaur; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

3.  Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.

Authors:  Elisa Nemes; Virginie Rozot; Hennie Geldenhuys; Nicole Bilek; Simbarashe Mabwe; Deborah Abrahams; Lebohang Makhethe; Mzwandile Erasmus; Alana Keyser; Asma Toefy; Yolundi Cloete; Frances Ratangee; Thomas Blauenfeldt; Morten Ruhwald; Gerhard Walzl; Bronwyn Smith; Andre G Loxton; Willem A Hanekom; Jason R Andrews; Maria D Lempicki; Ruth Ellis; Ann M Ginsberg; Mark Hatherill; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

4.  The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.

Authors:  Jason R Andrews; Mark Hatherill; Hassan Mahomed; Willem A Hanekom; Monica Campo; Thomas R Hawn; Robin Wood; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

Review 5.  Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.

Authors:  Saloua Tagmouti; Madeline Slater; Andrea Benedetti; Sandra V Kik; Niaz Banaei; Adithya Cattamanchi; John Metcalfe; David Dowdy; Richard van Zyl Smit; Nandini Dendukuri; Madhukar Pai; Claudia Denkinger
Journal:  Ann Am Thorac Soc       Date:  2014-10

Review 6.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

7.  Effect of prolonged incubation time on results of the QuantiFERON TB gold in-tube assay for diagnosis of latent tuberculosis infection.

Authors:  Joo-Won Min; Ha-Youn Lee; Ji Sun Lee; Jinwoo Lee; Jae Ho Chung; Sung Koo Han; Jae-Joon Yim
Journal:  Clin Vaccine Immunol       Date:  2013-07-03

8.  Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia.

Authors:  Mengistu Legesse; Gobena Ameni; Gezahegne Mamo; Girmay Medhin; Gunnar Bjune; Fekadu Abebe
Journal:  BMC Infect Dis       Date:  2010-12-17       Impact factor: 3.090

9.  Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?

Authors:  Mohammed Ahmed Yassin; Roberta Petrucci; Kefyalew Taye Garie; Gregory Harper; Isabel Arbide; Melkamsew Aschalew; Yared Merid; Zelalem Kebede; Amin Ahmed Bawazir; Nabil Mohamed Abuamer; Luis Eduardo Cuevas
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

Review 10.  Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.

Authors:  Miguel Santin; Laura Muñoz; David Rigau
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.